UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000029370
Receipt number R000033565
Scientific Title Appraisal of security and feasibility of laparoscopic sleeve gastrectomy in bariatric surgery in single institution
Date of disclosure of the study information 2017/12/01
Last modified on 2021/10/06 13:15:10

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Appraisal of security and feasibility of laparoscopic sleeve gastrectomy in bariatric surgery in single institution

Acronym

Appraisal of security and feasibility of laparoscopic sleeve gastrectomy in bariatric surgery

Scientific Title

Appraisal of security and feasibility of laparoscopic sleeve gastrectomy in bariatric surgery in single institution

Scientific Title:Acronym

Appraisal of security and feasibility of laparoscopic sleeve gastrectomy in bariatric surgery

Region

Japan


Condition

Condition

Highly obese patients with BMI> 35kg/m2 and one or more complications including diabetes mellitus, hypertension, dyslipidemia, liver dysfunction, sleep apnea syndrome etc. with BMI> 30 kg

Classification by specialty

Endocrinology and Metabolism Gastrointestinal surgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the safety and effectiveness
of laparoscopic sleeve gastrectomy for bariatric surgery

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

To evaluate the safety of laparoscopic
sleeve gastrectomy for bariatric surgery

Key secondary outcomes

To evaluate the effectiveness
of laparoscopic sleeve gastrectomy for bariatric surgery


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

laparoscopic sleeve gastrectomy

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

65 years-old >=

Gender

Male and Female

Key inclusion criteria


Primary obese patient with age from 18 to 65 year old and neither significant improvement in weight loss nor complications associated with obesity is observed despite medical treatment for 6 months or more.
Furthermore, patients should be fulfilled one of the following conditions
1.weight loss as a primary purpose of surgery (Bariatric Surgery) is BMI 35kg/m2
or more.
2.for metabolic surgery as the main
purpose of treatment for complications
including at least one as follows,
diabetes, hypertension, dyslipidemia,

Key exclusion criteria

1) When mental illness with poor control is merged
2) In addition, patients who are deemed as inappropriate by researcher.

Target sample size

10


Research contact person

Name of lead principal investigator

1st name Kazuhiro
Middle name
Last name Hiramatsu

Organization

Toyohasi Municipal Hospital

Division name

Department of general surgery

Zip code

441-8570

Address

50 hakken-nish Aotake-Cho Toyohashi City Aichi Japan

TEL

0532336111

Email

kazuhirohiramatsumd@yahoo.co.jp


Public contact

Name of contact person

1st name Kazuhiro
Middle name
Last name Hiramatsu

Organization

Toyohasi Municipal Hospital

Division name

Department of general surgery

Zip code

441-8570

Address

50 hakken-nish Aotake-Cho Toyohashi City Aichi Japan

TEL

0532336111

Homepage URL

https://www.municipal-hospital.toyohashi.aichi.jp/

Email

kazuhirohiramatsumd@yahoo.co.jp


Sponsor or person

Institute

Toyohashi Municipal Hospital

Institute

Department

Personal name



Funding Source

Organization

Toyohashi Municipal Hospital

Organization

Division

Category of Funding Organization

Local Government

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

supporting-office of IRB

Address

50 Hakken-Nishi Aotake-Cho Toyohashi Japan

Tel

0532336111

Email

supporting-office@toyohashi-mh.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 12 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2017 Year 11 Month 30 Day

Date of IRB

2017 Year 11 Month 16 Day

Anticipated trial start date

2018 Year 01 Month 15 Day

Last follow-up date

2021 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 10 Month 01 Day

Last modified on

2021 Year 10 Month 06 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033565